MCID: NDL009
MIFTS: 36

Nodular Basal Cell Carcinoma

Categories: Cancer diseases, Skin diseases

Aliases & Classifications for Nodular Basal Cell Carcinoma

MalaCards integrated aliases for Nodular Basal Cell Carcinoma:

Name: Nodular Basal Cell Carcinoma 12 15
Skin Nodulo-Ulcerative Basal Cell Carcinoma 12
Circumscribed Solid Basal Cell Carcinoma 12
Skin Nodular Solid Basal Cell Carcinoma 74
Nodulo-Ulcerative Basal Cell Carcinoma 74
Skin Solid Basal Cell Carcinoma 12
Skin Nodular Basal Cell Carcinoma 74
Basal Cell Carcinoma, Nodular 12

Classifications:



External Ids:

Disease Ontology 12 DOID:4280
NCIt 51 C62282

Summaries for Nodular Basal Cell Carcinoma

Disease Ontology : 12 A basal cell carcinoma characterized by elevated, pearl shaped nodules with telengactisae on the surface and periphery.

MalaCards based summary : Nodular Basal Cell Carcinoma, also known as skin nodulo-ulcerative basal cell carcinoma, is related to basal cell carcinoma and infiltrative basal cell carcinoma. An important gene associated with Nodular Basal Cell Carcinoma is WNT16 (Wnt Family Member 16), and among its related pathways/superpathways are Pathways in cancer and Keratinization. The drugs Imiquimod and interferons have been mentioned in the context of this disorder. Affiliated tissues include skin.

Related Diseases for Nodular Basal Cell Carcinoma

Graphical network of the top 20 diseases related to Nodular Basal Cell Carcinoma:



Diseases related to Nodular Basal Cell Carcinoma

Symptoms & Phenotypes for Nodular Basal Cell Carcinoma

Drugs & Therapeutics for Nodular Basal Cell Carcinoma

Drugs for Nodular Basal Cell Carcinoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 21)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Imiquimod Approved, Investigational Phase 4,Phase 3,Not Applicable 99011-02-6 57469
2 interferons Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
3 Interferon Inducers Phase 4,Phase 3,Not Applicable
4 Adjuvants, Immunologic Phase 4,Phase 3,Not Applicable
5 Immunologic Factors Phase 4,Phase 3,Not Applicable
6
Aminolevulinic acid Approved Phase 3,Phase 2,Phase 1,Not Applicable 106-60-5 137
7 Methyl 5-aminolevulinate Phase 3,Phase 2,Phase 1,Not Applicable
8 Dermatologic Agents Phase 3,Phase 2,Phase 1,Not Applicable
9 Photosensitizing Agents Phase 3,Phase 2,Phase 1,Not Applicable
10 Anesthetics Phase 3
11
Fluorouracil Approved Phase 1, Phase 2,Phase 2 51-21-8 3385
12
Cisplatin Approved Phase 1, Phase 2 15663-27-1 441203 84093 2767
13 Interferon-gamma Phase 1, Phase 2
14 Veratrum Alkaloids Phase 2
15 Antihypertensive Agents Phase 2
16 Pharmaceutical Solutions Phase 1, Phase 2
17
Doxorubicin Approved, Investigational Phase 1 23214-92-8 31703
18
Doxil Approved June 1999 Phase 1 31703
19 Antibiotics, Antitubercular Phase 1
20 Topoisomerase Inhibitors Phase 1
21 Anti-Bacterial Agents Phase 1

Interventional clinical trials:

(show all 17)
# Name Status NCT ID Phase Drugs
1 Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage Completed NCT00314756 Phase 4 imiquimod
2 Safety and Efficacy Study of Imiquimod 5% Cream Applied 3x Per Week for 8 or 12 Weeks in Low Risk Nodular Basal Cell Carcinoma Completed NCT00204555 Phase 4 Imiquimod
3 Photodynamic Therapy (PDT) With Metvix Cream 160 mg/g Versus PDT With Placebo Cream in Patients With Primary Nodular Basal Cell Carcinoma Completed NCT00472108 Phase 3
4 Fractional CO2 Laser Assisted Photodynamic Therapy Completed NCT01260987 Phase 2, Phase 3 Conventional photodynamic therapy;Fractional CO2 laser assisted PDT
5 PDT With Metvix 160 mg/g Cream Versus PDT With Placebo Cream in Patients With Primary Nodular Basal Call Carcinoma Completed NCT00472043 Phase 3
6 Surgery Versus Combined Treatment With Curettage and Imiquimod for Nodular Basal Cell Carcinoma Active, not recruiting NCT02242929 Phase 3 Imiquimod 5% cream with prior curettage
7 A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma Completed NCT02550678 Phase 1, Phase 2 5-FU
8 Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Nodular Basal Cell Carcinoma Completed NCT00108121 Phase 2 PEP005
9 Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle Applied Once or Twice Daily to Decrease the GLI1 Biomarker in Sporadic Nodular Basal Cell Carcinomas Completed NCT02828111 Phase 2 Patidegib;Vehicle gel
10 Basal Cell Carcinomas Treated With Ablative Fractional Laser and Ingenol Mebutate Completed NCT03569345 Phase 1, Phase 2 AFXl-assisted ingenol mebutate delivery
11 Topical Laser-assisted Combination Chemotherapy for Basal Cell Carcinoma― a Clinical Study Recruiting NCT03541252 Phase 1, Phase 2 AFL-assisted cisplatin+5-FU
12 Efficacy and Safety Trial of Topical Resiquimod Gel (0.06%) in Patients With Nodular Basal Cell Carcinoma Terminated NCT01808950 Phase 1, Phase 2 0.06% Resiquimod Gel - A;0.06% Resiquimod Gel - B;0.06% Resiquimod Gel - C
13 Er:YAG Ablative Fractional Laser Assisted-Photodynamic Therapy Versus Photodynamic Therapy for Basal Cell Carcinoma Completed NCT02018679 Phase 1
14 Open-Label Dose Escalation Trial to Evaluate Dose Limiting Toxicity and Maximum Tolerated Dose of Microneedle Arrays Containing Doxorubicin (D-MNA) in Basal Cell Carcinoma Not yet recruiting NCT03646188 Phase 1 Placebo-containing MNA;25 µg doxorubicin-containing MNA;50 µg doxorubicin-containing MNA;100 µg doxorubicin-containing MNA;200 µg doxorubicin-containing MNA
15 A Pilot Study of the Treatment of Facial Nodular and Nodulocystic Basal Cell Carcinoma With Double Curettage and Cautery Followed by Application of Imiquimod to the Base Unknown status NCT00463359 Not Applicable Imiquimod cream
16 Randomized Pilot Study of Treatment for BCC Using the Multiplex 595/1064 nm Laser Completed NCT02270645 Not Applicable
17 New Versus Approved Methyl-aminolevulinate Photodynamic Therapy (MAL-PDT) Regime in Basal Cell Carcinoma (BCC) Completed NCT01482104 Not Applicable MAL-PDT re-treatment;usual MAL-PDT

Search NIH Clinical Center for Nodular Basal Cell Carcinoma

Genetic Tests for Nodular Basal Cell Carcinoma

Anatomical Context for Nodular Basal Cell Carcinoma

MalaCards organs/tissues related to Nodular Basal Cell Carcinoma:

42
Skin

Publications for Nodular Basal Cell Carcinoma

Articles related to Nodular Basal Cell Carcinoma:

(show top 50) (show all 80)
# Title Authors Year
1
Successful Utilization of Optical Coherence Tomography as a Non-Invasive, Bedside Imaging Technique To Identify Residual Nodular Basal Cell Carcinoma at Well-Healed and Clinically Unidentifiable Biopsy Site. ( 30771419 )
2019
2
Excision of nodular basal cell carcinoma involving the lower eyelid tarsal skin using a grey line-splitting, posterior lamella-sparing technique. ( 29461902 )
2018
3
Nodular basal cell carcinoma of the face successfully treated with ingenol mebutate 0.015% gel. ( 29785331 )
2018
4
Ultrasonographic features of superficial and nodular basal cell carcinoma. ( 30534655 )
2018
5
Macrophage subtypes in recurrent nodular basal cell carcinoma after Mohs micrographic surgery. ( 28994114 )
2017
6
A rare dermoscopic pattern of nodular basal cell carcinoma with amyloid deposition. ( 28087032 )
2017
7
Imiquimod 5% cream for the treatment of large nodular basal cell carcinoma at the medial canthal area. ( 28300740 )
2017
8
Fibroepithelioma of Pinkus in continuity with nodular basal cell carcinoma: A rare presentation. ( 27559504 )
2016
9
Electronic brachytherapy for superficial and nodular basal cell carcinoma: a report of two prospective pilot trials using different doses. ( 26985197 )
2016
10
The effect of topical diclofenac 3% and calcitriol 3A I1g/g on superficial basal cell carcinoma (sBCC) and nodular basal cell carcinoma (nBCC): A phase II, randomized controlled trial. ( 27067393 )
2016
11
Altered Expression of PRKX, WNT3 and WNT16 in Human Nodular Basal Cell Carcinoma. ( 27630294 )
2016
12
Fibroepithelioma of Pinkus in continuity with a pigmented nodular basal cell carcinoma (BCC): A dermoscopic and histologic correlation. ( 27085246 )
2016
13
A retrospective study on the effectiveness of curettage and electrodesiccation for clinically suspected primary nodular basal cell carcinoma. ( 27229620 )
2016
14
Use of clamping to enhance intralesional bleomycin therapy for nodular basal cell carcinoma. ( 27075125 )
2015
15
Differentiating Early Stage Cystic Keratoacanthoma, Nodular Basal Cell Carcinoma, and Excoriated Acne Vulgaris by Clinical Exam, Dermoscopy, and Optical Coherence Tomography: A Report of 3 Cases. ( 26060518 )
2015
16
Imiquimod cream efficacy in the treatment of periocular nodular basal cell carcinoma: a non-randomized trial. ( 25885553 )
2015
17
Er:YAG ablative fractional laser-primed photodynamic therapy with methyl aminolevulinate as an alternative treatment option for patients with thin nodular basal cell carcinoma: 12-month follow-up results of a randomized, prospective, comparative trial. ( 26551044 )
2015
18
Imiquimod 5% as Adjuvant Therapy for Incompletely Excised Infiltrative Nodular Basal Cell Carcinoma and Dermoscopy to Monitor Treatment Response. ( 26538104 )
2015
19
Efficacy and safety of electronic brachytherapy for superficial and nodular basal cell carcinoma. ( 26207112 )
2015
20
Confocal microscopy-guided laser ablation for superficial and early nodular Basal cell carcinoma: a promising surgical alternative for superficial skin cancers. ( 24827701 )
2014
21
Dermoscopy margin delineation in radiotherapy planning for superficial or nodular basal cell carcinoma. ( 25204461 )
2014
22
Nodular Basal cell carcinoma arising in a split-thickness skin graft of the scalp. ( 23241812 )
2013
23
The rate and pattern of bcl-2 and cytokeratin 15 expression in trichoepithelioma and nodular Basal cell carcinoma: a comparative study. ( 24082173 )
2013
24
Photodynamic therapy combined with cryotherapy for the treatment of nodular basal cell carcinoma. ( 24137440 )
2013
25
Fractional carbon dioxide laser improves nodular basal cell carcinoma treatment with photodynamic therapy with methyl 5-aminolevulinate. ( 23725586 )
2013
26
Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up. ( 23566914 )
2013
27
First-in-human trial of Dz13 for nodular basal-cell carcinoma. ( 23660122 )
2013
28
Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER). ( 23660123 )
2013
29
The time-dependent accumulation of protoporphyrin IX fluorescence in nodular basal cell carcinoma following application of methyl aminolevulinate with an oxygen pressure injection device. ( 23092624 )
2012
30
Treatment of nodular basal cell carcinoma with cryotherapy and reduced protocol of imiquimod. ( 23270198 )
2012
31
Nodular Basal cell carcinoma successfully treated with intralesional 5-aminolevulinic Acid injection-photodynamic therapy. ( 23197924 )
2012
32
Photodynamic therapy with intralesional photosensitizer and laser beam application: an alternative treatment for nodular basal cell carcinoma. ( 22980263 )
2012
33
Imiquimod 5% cream as pretreatment of Mohs micrographic surgery for nodular basal cell carcinoma in the face: a prospective randomized controlled study. ( 22385074 )
2012
34
Nodular basal cell carcinoma is associated with increased hyaluronan homeostasis. ( 20849445 )
2011
35
No-needle jet intradermal aminolevulinic Acid photodynamic therapy for recurrent nodular Basal cell carcinoma of the nose: a case report. ( 21188233 )
2011
36
Fibroepithelioma of pinkus in continuity with nodular basal cell carcinoma: supporting evidence of the malignant nature of the disease. ( 20512537 )
2011
37
Central nuclear palisading in nodular basal cell carcinoma: Morphological and immunohisto-chemical concerns. ( 21088810 )
2011
38
Targeting superficial or nodular Basal cell carcinoma with topically formulated small molecule inhibitor of smoothened. ( 21558397 )
2011
39
Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma: further explanation of a dose-escalating pilot study conducted primarily to consider the safety of this pharmacological modification. ( 19903172 )
2010
40
Probing tumor and peritumoral tissues in superficial and nodular basal cell carcinoma using polarized Raman microspectroscopy. ( 19845756 )
2010
41
Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies. ( 20064185 )
2009
42
Imiquimod-induced vitiligo after treatment of nodular basal cell carcinoma. ( 19586497 )
2009
43
Case study: Imiquimod 5% cream in the treatment of a large nodular basal cell carcinoma. ( 19507375 )
2009
44
Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma: when statistics make a difference. ( 19438852 )
2009
45
Randomized comparison of Mohs micrographic surgery and surgical excision for small nodular basal cell carcinoma: tissue-sparing outcome. ( 19500127 )
2009
46
Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma. ( 18544077 )
2008
47
Complete remission of nodular basal cell carcinoma after combined treatment with photodynamic therapy and imiquimod 5% cream. ( 18700128 )
2008
48
Enhancement of methyl-aminolevulinate photodynamic therapy by iron chelation with CP94: an in vitro investigation and clinical dose-escalating safety study for the treatment of nodular basal cell carcinoma. ( 18239941 )
2008
49
Fractionated 5-aminolaevulinic acid-photodynamic therapy vs. surgical excision in the treatment of nodular basal cell carcinoma: results of a randomized controlled trial. ( 18717680 )
2008
50
Combination of Er:YAG laser and photodynamic therapy in the treatment of nodular basal cell carcinoma. ( 18306163 )
2008

Variations for Nodular Basal Cell Carcinoma

Cosmic variations for Nodular Basal Cell Carcinoma:

9 (show top 50) (show all 687)
# Cosmic Mut ID Gene Symbol COSMIC Disease Classification
(Primary site, Site subtype, Primary histology, Histology subtype)
Mutation CDS Mutation AA GRCh38 Location Conf
1 COSM3691166 ZFHX3 skin,NS,carcinoma,basal cell carcinoma c.2084C>T p.P695L 16:72958062-72958062 0
2 COSM6926860 ZFHX3 skin,NS,carcinoma,basal cell carcinoma c.5825G>A p.G1942E 16:72796857-72796857 0
3 COSM6926861 ZFHX3 skin,NS,carcinoma,basal cell carcinoma c.1655C>T p.S552F 16:72958491-72958491 0
4 COSM6969201 ZFHX3 skin,NS,carcinoma,basal cell carcinoma c.11050G>A p.D3684N 16:72787226-72787226 0
5 COSM6953811 ZFHX3 skin,NS,carcinoma,basal cell carcinoma c.1991C>T p.S664F 16:72958155-72958155 0
6 COSM6926862 ZFHX3 skin,NS,carcinoma,basal cell carcinoma c.1261G>A p.G421R 16:72958885-72958885 0
7 COSM6936924 ZFHX3 skin,NS,carcinoma,basal cell carcinoma c.10847C>T p.S3616F 16:72787429-72787429 0
8 COSM212945 XPO1 skin,NS,carcinoma,basal cell carcinoma c.782G>A p.R261Q 2:61496985-61496985 0
9 COSM6936922 TSC2 skin,NS,carcinoma,basal cell carcinoma c.2060C>T p.S687F 16:2071897-2071897 0
10 COSM6926855 TSC2 skin,NS,carcinoma,basal cell carcinoma c.679T>A p.C227S 16:2056674-2056674 0
11 COSM6953809 TSC2 skin,NS,carcinoma,basal cell carcinoma c.869C>T p.P290L 16:2058767-2058767 0
12 COSM6912933 TRAF7 skin,NS,carcinoma,basal cell carcinoma c.1802C>T p.T601I 16:2176104-2176104 0
13 COSM6949578 TP63 skin,NS,carcinoma,basal cell carcinoma c.1922C>T p.A641V 3:189894381-189894381 0
14 COSM44097 TP53 skin,NS,carcinoma,basal cell carcinoma c.530C>T p.P177L 17:7675082-7675082 0
15 COSM44071 TP53 skin,NS,carcinoma,basal cell carcinoma c.955A>G p.K319E 17:7673573-7673573 0
16 COSM44096 TP53 skin,NS,carcinoma,basal cell carcinoma c.748C>G p.P250A 17:7674215-7674215 0
17 COSM45751 TP53 skin,NS,carcinoma,basal cell carcinoma c.511G>C p.E171Q 17:7675101-7675101 0
18 COSM10768 TP53 skin,NS,carcinoma,basal cell carcinoma c.535C>T p.H179Y 17:7675077-7675077 0
19 COSM10887 TP53 skin,NS,carcinoma,basal cell carcinoma c.833C>G p.P278R 17:7673787-7673787 0
20 COSM10728 TP53 skin,NS,carcinoma,basal cell carcinoma c.839G>A p.R280K 17:7673781-7673781 0
21 COSM45739 TP53 skin,NS,carcinoma,basal cell carcinoma c.677G>C p.G226A 17:7674286-7674286 0
22 COSM44295 TP53 skin,NS,carcinoma,basal cell carcinoma c.993+1G>A p.? 17:7673534-7673534 0
23 COSM43778 TP53 skin,NS,carcinoma,basal cell carcinoma c.713G>T p.C238F 17:7674250-7674250 0
24 COSM10939 TP53 skin,NS,carcinoma,basal cell carcinoma c.832C>T p.P278S 17:7673788-7673788 0
25 COSM10650 TP53 skin,NS,carcinoma,basal cell carcinoma c.529C>T p.P177S 17:7675083-7675083 0
26 COSM43665 TP53 skin,NS,carcinoma,basal cell carcinoma c.746G>C p.R249T 17:7674217-7674217 0
27 COSM10662 TP53 skin,NS,carcinoma,basal cell carcinoma c.743G>A p.R248Q 17:7674220-7674220 0
28 COSM45774 TP53 skin,NS,carcinoma,basal cell carcinoma c.899C>G p.P300R 17:7673721-7673721 0
29 COSM10749 TP53 skin,NS,carcinoma,basal cell carcinoma c.830G>T p.C277F 17:7673790-7673790 0
30 COSM11449 TP53 skin,NS,carcinoma,basal cell carcinoma c.388C>T p.L130F 17:7675224-7675224 0
31 COSM10660 TP53 skin,NS,carcinoma,basal cell carcinoma c.818G>A p.R273H 17:7673802-7673802 0
32 COSM44068 TP53 skin,NS,carcinoma,basal cell carcinoma c.532C>A p.H178N 17:7675080-7675080 0
33 COSM10771 TP53 skin,NS,carcinoma,basal cell carcinoma c.749C>T p.P250L 17:7674214-7674214 0
34 COSM11152 TP53 skin,NS,carcinoma,basal cell carcinoma c.700T>C p.Y234H 17:7674263-7674263 0
35 COSM43582 TP53 skin,NS,carcinoma,basal cell carcinoma c.454C>T p.P152S 17:7675158-7675158 0
36 COSM45834 TP53 skin,NS,carcinoma,basal cell carcinoma c.409C>A p.L137M 17:7675203-7675203 0
37 COSM10905 TP53 skin,NS,carcinoma,basal cell carcinoma c.451C>T p.P151S 17:7675161-7675161 0
38 COSM10654 TP53 skin,NS,carcinoma,basal cell carcinoma c.637C>T p.R213* 17:7674894-7674894 0
39 COSM45424 TP53 skin,NS,carcinoma,basal cell carcinoma c.781A>T p.S261C 17:7674182-7674182 0
40 COSM10648 TP53 skin,NS,carcinoma,basal cell carcinoma c.524G>A p.R175H 17:7675088-7675088 0
41 COSM6932 TP53 skin,NS,carcinoma,basal cell carcinoma c.733G>A p.G245S 17:7674230-7674230 0
42 COSM10812 TP53 skin,NS,carcinoma,basal cell carcinoma c.722C>T p.S241F 17:7674241-7674241 0
43 COSM10656 TP53 skin,NS,carcinoma,basal cell carcinoma c.742C>T p.R248W 17:7674221-7674221 0
44 COSM10659 TP53 skin,NS,carcinoma,basal cell carcinoma c.817C>T p.R273C 17:7673803-7673803 0
45 COSM10794 TP53 skin,NS,carcinoma,basal cell carcinoma c.796G>A p.G266R 17:7673824-7673824 0
46 COSM44552 TP53 skin,NS,carcinoma,basal cell carcinoma c.509C>T p.T170M 17:7675103-7675103 0
47 COSM10704 TP53 skin,NS,carcinoma,basal cell carcinoma c.844C>T p.R282W 17:7673776-7673776 0
48 COSM10726 TP53 skin,NS,carcinoma,basal cell carcinoma c.856G>A p.E286K 17:7673764-7673764 0
49 COSM6549 TP53 skin,NS,carcinoma,basal cell carcinoma c.743G>T p.R248L 17:7674220-7674220 0
50 COSM45304 TP53 skin,NS,carcinoma,basal cell carcinoma c.375+1G>A p.? 17:7675993-7675993 0

Expression for Nodular Basal Cell Carcinoma

Search GEO for disease gene expression data for Nodular Basal Cell Carcinoma.

Pathways for Nodular Basal Cell Carcinoma

GO Terms for Nodular Basal Cell Carcinoma

Cellular components related to Nodular Basal Cell Carcinoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 endocytic vesicle membrane GO:0030666 8.96 PTCH1 WNT3
2 intermediate filament GO:0005882 8.92 BFSP1 KRT15 KRT17 KRT31

Biological processes related to Nodular Basal Cell Carcinoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 keratinization GO:0031424 9.5 KRT15 KRT17 KRT31
2 cell fate commitment GO:0045165 9.37 WNT16 WNT3
3 cornification GO:0070268 9.33 KRT15 KRT17 KRT31
4 keratinocyte proliferation GO:0043616 9.26 PTCH1 WNT16
5 cytoskeleton organization GO:0007010 9.26 BFSP1 KRT15 KRT17 KRT31
6 epidermis development GO:0008544 8.92 KRT15 KRT17 KRT31 PTCH1

Molecular functions related to Nodular Basal Cell Carcinoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 frizzled binding GO:0005109 8.96 WNT16 WNT3
2 structural constituent of cytoskeleton GO:0005200 8.92 BFSP1 KRT15 KRT17 KRT31

Sources for Nodular Basal Cell Carcinoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....